Pharmacology) and Peter opened the conference this year with a perspective of his research south of the Wallace line during the last five years. A highlight was the story of the aptly named "tasmanone" that exits as a mixture of two isomers related by a 1,3-sigmatropic shift.
Drug discovery has always been a major focus of natural products chemistry and Australia is no exception. Currently there are several drug companies (eg Astra-Zeneca, Novogen, Novartis and Biota) that are actively pursuing drug leads from Australian flora and fauna. We are lucky to have a paper in this issue from Mediherb, a small home-grown bioprospecting company who are interested in the chemical basis for herbal medicines. Marine natural products chemistry began in Australia in the early 1980's with the establishment of the Roche Research Institute for Marine Pharmacology (RRIMP) which met an untimely death in 1984 due to financial difficulties of the parent company. At the time, John Coll at James Cook University was already very active in the natural products of soft corals and other smaller groups existed in Tasmania, Western Australia and Sydney. Today, John's mantle has been taken up by Bruce Bowden and Macquarie University, Wollongong, Flinders and the University of Queensland can be added to the list of Universities involved in marine natural products research. In this issue we have several papers dealing with marine natural products, which range from the classical isolation of sponge natural products to new pigments from marine microorganisms. The second plenary lecture was given by Peter Steinberg from the Centre for Marine Biofouling, who related the tale of the understanding of bacterial quorum sensing discovered in part by the isolation of a potent inhibitor of quorum sensing from the Australian red alga Delisea pulchra. Natural products synthesis also featured in the conference (Kumar, Barrow) but there was a notably large number of papers on natural products from marine microorganisms -a largely untapped source of new compounds.
A way to increase the odds of finding biologically active compounds is to use ethnobotanical data. Three papers in this issue highlight this approach, two by Lehmann et al. from a traditional European perspective (Echinacea chemistry) and one by Jamie and co-workers about the largely untapped Australian Aboriginal pharmacopoeia, a pharmacopoeia that has developed in a megadiverse environment over the past 60,000 years, but one that has developed without written records and that has all but disappeared over the past 200 years.
Peter Waterman predicted that the future holds non-traditional applications for natural products, for example, the study of the environmental effects of natural products. He also warned that the role of the natural products chemist remains as a handmaiden to the other sciences. This rather impoverished view of natural products chemistry denies its historic role in drug discovery, a role that will become more important in the future because alternate strategies such as combinatorial chemistry have been patently unsuccessful in filling the drug companies' product pipelines. Natural products chemists hold the keys as Craig Crew (Yale University) recently told me, but the question remains: the keys to what?
Reactions in nature are biased toward function. This notion sits well with our Darwinian notion of evolution and survival of the fittest, but also helps explain the enormous biochemical expense of storing and maintaining the information required to make natural products (DNA) and the means to make them (enzymes and substrates). It follows then that that every natural product must have a biological receptor and that receptor may not be that different from a human protein [2] . This is supported by recent data on new small molecule chemical entities introduced by the pharma industry from 1981-2002, which revealed that 61% were natural products or derived from natural product leads [3] . This percentage is even higher when considering only anticancer compounds (74%) or antibacterials (79%). Clearly, natural products chemists hold the keys to a rich source of drugs and drug leads.
Whether chemists turn to ethnopharmacological data, plants, microorganisms or the marine environment, there is a rich bounty of new chemicals -all of which must be biosynthesized for a purpose. Perhaps it is time for natural products chemist to find out what that purpose is [4] . I hope you enjoy this collection of papers from the 2004 RACI One-day Natural Products Group Symposium.
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